Azithromycin for Meningococcal Carriage — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Azithromycin for Meningococcal Carriage — Stella

Recruiting

Back to Meningococcal Infections trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Hope Clinic of the Emory Vaccine Center, Decatur, Georgia

Key details

Phase

Safety & dosing

Sponsor

Emory University

Collaborators

Centers for Disease Control and Prevention, Georgia Department of Public Health

Enrollment target

~1,120 participants

Started

November 2024

Primary completion

May 2026

Age range

18 Years – 25 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov